SAM
SAGE

Shell Asset Management’s Sage Therapeutics SAGE Stock Holding History

Shell Asset Management’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-7,405
Closed -$282K – 1316
2022
Q4 		$282K Sell
7,405
-1,556
-17% -$59.4K 0.01% 810
2022
Q3 		$351K Sell
8,961
-2,348
-21% -$90.8K 0.01% 752
2022
Q2 		$365K Buy
11,309
+18
+0.2% +$603 0.01% 884
2022
Q1 		$374K Sell
11,291
-1,672
-13% -$62.9K 0.01% 950
2021
Q4 		$551K Buy
12,963
+2,712
+26% +$114K 0.01% 858
2021
Q3 		$454K Sell
10,251
-440
-4% -$20.2K 0.01% 915
2021
Q2 		$607K Buy
10,691
+580
+6% +$41K 0.01% 825
2021
Q1 		$757K Buy
10,111
+5,723
+130% +$469K 0.02% 654
2020
Q4 		$380K Hold
4,388
– – 0.01% 908
2020
Q3 		$268K Hold
4,388
– – 0.01% 950
2020
Q2 		$182K Sell
4,388
-85
-2% -$3.08K ﹤0.01% 1044
2020
Q1 		$128K Sell
4,473
-70
-2% -$4.05K ﹤0.01% 1087
2019
Q4 		$328K Sell
4,543
-132
-3% -$16.2K 0.01% 1034
2019
Q3 		$656K Sell
4,675
-40
-0.8% -$6.69K 0.02% 749
2019
Q2 		$863K Sell
4,715
-109
-2% -$18.6K 0.02% 628
2019
Q1 		$767K Buy
4,824
+2,404
+99% +$348K 0.02% 705
2018
Q4 		$232K Sell
2,420
-200
-8% -$22.9K 0.01% 1020
2018
Q3 		$370K Hold
2,620
– – 0.01% 1034
2018
Q2 		$410K Sell
2,620
-100
-4% -$15.7K 0.01% 977
2018
Q1 		$438K Buy
+2,720
New +$462K 0.01% 946

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Shell Asset Management's SAGE Position: Q1 2023 in Review

Shell Asset Management sold out of Sage Therapeutics (SAGE) in Q1 2023, closing a stake of 7,405 shares — an estimated $282K sold.

Shell Asset Management first reported a position in SAGE in Q1 2018 and held it in 20 quarters. The position peaked at $863K in Q2 2019. 213 funds tracked by Wall St. Rank hold SAGE as of Q1 2023.

  • Shell Asset Management reported no remaining Sage Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Shell Asset Management sold 7,405 Sage Therapeutics shares in Q1 2023, an estimated $282K.
  • Shell Asset Management first reported a position in Sage Therapeutics in Q1 2018 and held it in 20 quarters.
  • Shell Asset Management's Sage Therapeutics position peaked at $863K in Q2 2019.
  • 213 funds tracked by Wall St. Rank held Sage Therapeutics as of Q1 2023.

Based on Shell Asset Management's 13F filing for Q1 2023, filed 15 May 2023.